Pediatrix Medical
MD | NYSE
$31.89
+$0.59 (+1.88%)
At close: Nov 16, 2026, 4:00 PM ET
$31.89
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:01 PM ET
Pediatrix Medical Company Profile
Company profile explainedCompany Profile
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
Key Executives
| Name | Position |
|---|---|
| Mark S. Ordan | Chief Executive Officer & Executive Chairman |
| Cheryl VanPatten | Senior Vice President & Chief Information Officer |
| Kasandra H. Rossi | Executive Vice President, Treasurer & Chief Financial Officer |
| D. Gregory Neeb | Executive VP & Chief Operating and Strategy Officer |
| David Haddock | Executive Vice President, General Counsel & Secretary |
| Debra McRoberts | Senior Vice President of People Services |
| John C. Pepia | Senior Vice President & Chief Accounting Officer |
| Kevin Pitzer | President of West Division |
| Mary Ann E. Moore | Advisor |
| Mike Ashford | President of South Central Division |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 10-Q | Quarterly Report |
| Oct 29, 2026 | 8-K | Current Report |
| Sep 14, 2026 | 144 | Filing |
| Sep 14, 2026 | 144 | Filing |
| Sep 14, 2026 | 4 | Filing |
| Sep 10, 2026 | 144 | Filing |
| Sep 03, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 03, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 03, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 18, 2026 | 4 | Filing |
Pediatrix Medical
| Country | United States |
| IPO Date | Sep 20, 1995 |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Employees | 4,280 |
| CEO | Mark S. Ordan |
Contact Details
1301 Concord Terrace Sunrise,
Florida 33323 United States
Stock Details
| Ticker Symbol | MD |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000893949 |
| CUSIP Number | 58502B106 |
| ISIN Number | US58502B1061 |
| SIC Code | 8060 |
Recent News
- 6 days ago / zacks.comWhat Makes Pediatrix Medical Group (MD) a Strong Momentum Stock: Buy Now?
- 11 days ago / zacks.comPediatrix Medical Group (MD) Upgraded to Buy: Here's What You Should Know
- 11 days ago / zacks.comHere's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
- 18 days ago / marketbeat.comWhat Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call
- 18 days ago / seekingalpha.comPediatrix Medical Group, Inc. (MD) Q3 2026 Earnings Call Transcript
- 19 days ago / zacks.comPediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates
- 19 days ago / businesswire.comPediatrix Medical Group Reports Third Quarter Results
- 28 days ago / businesswire.comPediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
- 1 month ago / zacks.comWhy Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
- 2 months ago / zacks.comCan Pediatrix Sustain Growth Despite Lower Patient Volumes?
Add to Watchlist
Select watchlists to add or remove MD